Juno Therapeutics Profile

86.96
1.14  1.33%
0%

Juno Therapeutics Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Juno Therapeutics Key Fundamentals

Juno Therapeutics Against Markets

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. Juno Therapeutics, Inc. was founded in 2013 and is headquartered in Seattle, Washington. Juno Therapeutics operates under Biotechnology classification in USA and traded on NASDAQ. It employs 589 people. more
NameJuno Therapeutics
CEOHans BishopView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address400 Dexter Avenue North
ExchangeNASDAQ
CIK Number0001594864
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.junotherapeutics.com
Phone206 582 1600

Juno Therapeutics Directors

Juno Therapeutics Corporate Directors

Hal Barron Director
Richard Klausner Director
Mary Wilderotter Independent Director
Please also check Risk vs Return Analysis. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com